Vida Diagnostics, Inc., a Coralville, Iowa-based precision pulmonary informatics company, completed a $5.1m equity financing.
The round was led by Chartline Capital Partners with participation from Rittenhouse Ventures, Next Level Ventures, Rural Vitality Fund II, Iowa Seed Fund, and Northern California Investment Fund.
The company intends to use the funds to hire additional people, and enhance its clinical software and services for pulmonary disease management, including lung cancer, COPD, and asthma.
Led by Susan A. Wood, Ph.D., President and CEO, Vida offers a lung informatics solution that is a combination of image analysis services (Precision Services) and software visualization and analytics (VIDA|vision). The solution spans both diagnostic and therapeutic planning applications. For suspected lung cancer patients, the company’s VIDA|vision provides interventional pulmonologists with airway mapping software to guide an optimal path for bronchoscopic biopsy. For severe emphysema patients, an array of advanced, clinically-validated measures to inform treatment selection to match the right patient to the right treatment, focusing on improving outcomes, are available.
The company also has an additional office in Minneapolis, MN.